Cargando…

Chickenpox and asymptomatic COVID-19 after first cycle of alemtuzumab for multiple sclerosis

Detalles Bibliográficos
Autor principal:	Habek, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Covid-19
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325041/ https://www.ncbi.nlm.nih.gov/pubmed/34331616 http://dx.doi.org/10.1007/s10072-021-05495-6

Ejemplares similares

SARS-CoV-2 infection after alemtuzumab in a multiple sclerosis patient: milder disease symptoms in comparison with coinfected relatives: a case report and review of the literature
por: Saraceno, Lorenzo, et al.
Publicado: (2021)

Miller Fisher syndrome following Pfizer COVID-19 vaccine
por: Abičić, Ana, et al.
Publicado: (2021)

COVID-19 and Multiple Sclerosis: Predisposition and Precautions in Treatment
por: Sadeghmousavi, Shaghayegh, et al.
Publicado: (2020)

Reliability of televisits for patients with mild relapsing–remitting multiple sclerosis in the COVID-19 era
por: Toscano, Simona, et al.
Publicado: (2022)

Descriptive epidemiology of the first wave of COVID-19 in Petaling District, Malaysia: Focus on asymptomatic transmission
por: Supramanian, Rama Krishna, et al.
Publicado: (2021)

Impact of COVID-19 lockdown on progressive multiple sclerosis patients
por: Vercellino, Marco, et al.
Publicado: (2022)

Are patients with multiple sclerosis (MS) at higher risk of COVID-19 infection?
por: Ghajarzadeh, Mahsa, et al.
Publicado: (2020)

Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic
por: Bonavita, Simona, et al.
Publicado: (2020)

COVID-19 vaccine hesitancy among Italian people with multiple sclerosis
por: Proietti, Francesca, et al.
Publicado: (2022)

Stress related to COVID-19 pandemic as a trigger for disease activity in multiple sclerosis: a case report
por: Giordano, Antonino, et al.
Publicado: (2021)

Worldwide Recommendations and Therapies for Multiple Sclerosis: Are They Safe in the COVID-19 Pandemic Period?
por: Ferrara, Francesco, et al.
Publicado: (2020)

Acute cerebellitis requiring posterior fossa decompression after COVID-19 vaccination in an ocrelizumab-treated patient with multiple sclerosis
por: Brecl Jakob, Gregor, et al.
Publicado: (2022)

MS and COVID-19 challenge: asymptomatic COVID-19 infection during treatment with cladribine
por: Seferoğlu, Meral, et al.
Publicado: (2021)

Association between relapses, stress, and depression in people with multiple sclerosis during the COVID-19 pandemic
por: Sparaco, Maddalena, et al.
Publicado: (2022)

Epidemiological characteristics and outcomes of COVID-19 in asymptomatic versus symptomatic patients
por: PIRAEE, ELAHE, et al.
Publicado: (2022)

The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysis
por: Moghadasi, Abdorreza Naser, et al.
Publicado: (2021)

Masked face recognition in patients with relapsing–remitting multiple sclerosis during the ongoing COVID-19 pandemic
por: Kuzu Kumcu, Müge, et al.
Publicado: (2022)

Follow-up investigation of asymptomatic COVID-19 cases at diagnosis in Busan, Korea
por: Lee, Miyoung, et al.
Publicado: (2020)

The role and relevance of asymptomatic healthcare worker testing in COVID-19 hospital outbreaks
por: Garrod, Matthew, et al.
Publicado: (2022)

Depression, anxiety, and fear of COVID-19 in patients with multiple sclerosis in pandemic era: a cross-sectional study
por: Alirezaei, Mohammad, et al.
Publicado: (2021)

Transient monocular visual impairment as an initial symptom of COVID-19 infection in an individual with multiple sclerosis receiving teriflunomide
por: Yetkin, Mehmet Fatih, et al.
Publicado: (2021)

Real-time assessment of COVID-19 prevalence among multiple sclerosis patients: a multicenter European study
por: Dalla Costa, Gloria, et al.
Publicado: (2020)

COVID-19 vaccines and patients with multiple sclerosis: willingness, unwillingness and hesitancy: a systematic review and meta-analysis
por: Yazdani, Amid, et al.
Publicado: (2022)

Progressive multifocal leukoencephalopathy or severe multiple sclerosis relapse following COVID-19 vaccine: a diagnostic challenge
por: D’Apolito, Maria, et al.
Publicado: (2023)

Impact of COVID-19 and system recovery in delivering healthcare to people with multiple sclerosis: a population-based Study
por: Affinito, Giuseppina, et al.
Publicado: (2023)

Mixed‐methods exploration of views on choice in a university asymptomatic COVID‐19 testing programme
por: Cox, Caitríona, et al.
Publicado: (2022)

Systematic review of risk of SARS-CoV-2 infection and severity of COVID-19 with therapies approved to treat multiple sclerosis
por: Hada, Manila, et al.
Publicado: (2022)

Effects of quarantine applied during the COVID-19 pandemic on mental health and quality of life in patients with multiple sclerosis and healthy controls
por: Koc, Emine Rabia, et al.
Publicado: (2022)

Assessing disability and relapses in multiple sclerosis on tele-neurology
por: Moccia, Marcello, et al.
Publicado: (2020)

Six-month humoral response to BNT162b2 mRNA COVID-19 vaccine in people with multiple sclerosis treated with natalizumab
por: Altieri, Manuela, et al.
Publicado: (2022)

Stroke admission rates before, during and after the first phase of the COVID-19 pandemic
por: Kristoffersen, Espen Saxhaug, et al.
Publicado: (2021)

Telemedicine and technological devices for amyotrophic lateral sclerosis in the era of COVID-19
por: De Marchi, Fabiola, et al.
Publicado: (2020)

Sociodemographic Factors, Cycle Threshold Values, and Clinical Outcomes of COVID-19
por: Rivera, Frida, et al.
Publicado: (2021)

New COVID-19 Transmission after the First Vaccine Dose at Skilled Nursing Facilities in Nebraska
por: Kamal-Ahmed, Ishrat, et al.
Publicado: (2021)

The impact of confirmed coronavirus disease 2019 (COVID-19) infection on ambulatory procedures and associated delays in care for asymptomatic patients
por: Larsen, Christopher G., et al.
Publicado: (2021)

Fear of relapse, social support, and psychological well-being (depression, anxiety, and stress level) of patients with multiple sclerosis (MS) during the COVID-19 pandemic stage
por: Shaygannejad, Vahid, et al.
Publicado: (2021)

Telemedicine for management of patients with amyotrophic lateral sclerosis through COVID-19 tail
por: Bombaci, Alessandro, et al.
Publicado: (2020)

Coronavirus disease 2019: favorable outcome in an immunosuppressed patient with multiple sclerosis
por: Devogelaere, Jens, et al.
Publicado: (2020)

Post-COVID-19 health-care utilization: one year after the 2020 first wave in  Brunei Darussalam
por: Abdullah, Muhammad Syafiq, et al.
Publicado: (2023)

Postoperative Onset and Detection of SARS-CoV-2 in Surgically Resected Specimens From Gastrointestinal Cancer Patients With Pre/Asymptomatic COVID-19
por: Liu, Yan-Liang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tnenkor66k7md3crasu7r85os3